Northwestern Mutual Wealth Management
VYGR icon

Northwestern Mutual Wealth Management’s Voyager Therapeutics VYGR Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28
Closed -$110 – 4489
2025
Q4 		$110 Buy
+28
New +$124 ﹤0.01% 3847

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northwestern Mutual Wealth Management's VYGR Position: Q1 2026 in Review

Northwestern Mutual Wealth Management sold out of Voyager Therapeutics (VYGR) in Q1 2026, closing a stake of 28 shares — an estimated $110 sold.

Northwestern Mutual Wealth Management first reported a position in VYGR in Q4 2025 and held it in 1 quarter. The position peaked at $110 in Q4 2025. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • Northwestern Mutual Wealth Management reported no remaining Voyager Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 28 Voyager Therapeutics shares in Q1 2026, an estimated $110.
  • Northwestern Mutual Wealth Management first reported a position in Voyager Therapeutics in Q4 2025 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's Voyager Therapeutics position peaked at $110 in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.